We support projects that cover the range of understanding BHD syndrome, from basic research to therapeutic development. Researchers are currently investigating the biochemical processes in which Folliculin is involved and learning about its structure to understand the function of Folliculin. Research is ongoing to identify drugs to treat symptoms of BHD syndrome. Many of the investigators we work with are also involved in clinical research, such as analysing the risk of renal cancer.
We currently support more than a dozen projects, including the following:
Professor Eamonn Maher: Investigating the molecular basis of Birt-Hogg-Dubé syndrome |
Dr Ravi Nookala: Structural characterisation of protein complexes important in Birt-Hogg-Dubé syndrome |
Dr Andrew Tee: The effect of amplified ROS production and elevated HIF activity in BHD-null cells |
